An accelerated background subtraction algorithm for processing high-resolution MS data and its application to metabolite identification

Bioanalysis. 2016 Aug;8(16):1693-707. doi: 10.4155/bio-2016-0101. Epub 2016 Jul 27.

Abstract

Background: Metabolite identification without radiolabeled compound is often challenging because of interference of matrix-related components.

Results: A novel and an effective background subtraction algorithm (A-BgS) has been developed to process high-resolution mass spectral data that can selectively remove matrix-related components. The use of a graphics processing unit with a multicore central processing unit enhanced processing speed several 1000-fold compared with a single central processing unit. A-BgS algorithm effectively removes background peaks from the mass spectra of biological matrices as demonstrated by the identification of metabolites of delavirdine and metoclopramide.

Conclusion: The A-BgS algorithm is fast, user friendly and provides reliable removal of matrix-related ions from biological samples, and thus can be very helpful in detection and identification of in vivo and in vitro metabolites.

Keywords: A-BgS; background subtraction; matrix interference; metabolite identification.

MeSH terms

  • Algorithms*
  • Animals
  • Bile / metabolism
  • Chromatography, High Pressure Liquid / economics
  • Chromatography, High Pressure Liquid / methods
  • Delavirdine / blood
  • Delavirdine / metabolism*
  • Delavirdine / urine
  • Dopamine D2 Receptor Antagonists / blood
  • Dopamine D2 Receptor Antagonists / metabolism*
  • Dopamine D2 Receptor Antagonists / urine
  • Mass Spectrometry / economics
  • Mass Spectrometry / methods*
  • Metoclopramide / blood
  • Metoclopramide / metabolism*
  • Metoclopramide / urine
  • Microsomes, Liver / metabolism
  • Rats
  • Reverse Transcriptase Inhibitors / blood
  • Reverse Transcriptase Inhibitors / metabolism*
  • Reverse Transcriptase Inhibitors / urine
  • Time Factors

Substances

  • Dopamine D2 Receptor Antagonists
  • Reverse Transcriptase Inhibitors
  • Delavirdine
  • Metoclopramide